Work

Perkembangan targeted therapy pada kanker payudara dengan pertimbangan luaran biaya dan kualitas hidup: narrative review

Year: 2024

Type: review

Abstract: Breast cancer is a malignant tumour that grows in the breast tissue and can spread to the lymph nodes and metastasize to other parts of the body. Targeted therapy is currently developed as a therapeutic management for breast cancer with hormone receptor positive/human epidermal growth factor receptor 2 negative (HR+/HER2-). This review aims to determine the effectiveness both in terms of clinical and cost on the use of single or combined targeted therapy when compared with conventional therapy, namely chemotherapy in breast cancer patients. The results show that the use of targeted therapy can provide greater health benefits in both single and combination use even though it can increase the cost of therapy.

Source: Sasambo Journal of Pharmacy

DOI: 10.29303/sjp.v5i2.448

Authors: Candra Eka Puspitasari, Janatul Annisa, Malva Marshaniswa Yasykurah, Baiq Hawarikatun

Institution: University of Mataram

Language: English

Topic: Breast Cancer Treatment Studies

Subfield: Cancer Research

Field: Biochemistry, Genetics and Molecular Biology

Domain: Life Sciences

SDG: Good health and well-being

Open Access status: diamond

OpenAlex ID: W4404320327

FWCI:

Cites:

Cited by:

Related to: 10